Venture Investors co-led a $21.5 million Series B financing round for EarliTec Diagnostics, a Georgia-based medical device company focused on diagnostic and therapeutic solutions for children with autism and related early childhood vulnerabilities, the companies announced recently.

“EarliTec is pioneering diagnostic and treatment solutions for children with autism, and we’re thrilled to support their innovative efforts,” Venture Investors Executive Managing Director Jim Adox said in a statement.

According to a release, the funds will be used to expand commercialization efforts and advance clinical research for EarliPoint Evaluation, a tool that aids clinicians in the diagnosis and assessment of autism in children ages 16-30 months.

Nexus NeuroTech Ventures was the other lead in the funding round.